Heather Moore, CPP, PharmD, highlights key contributions from pharmacists in breast cancer treatment and identifies current unmet needs in the treatment landscape.
email article
After close to a decade at the helm, Richard Schilsky, MD, has retired from his role as chief medical officer of the American Society of Clinical Oncology (ASCO).
His legacy as the organization s first CMO will be what he calls the ASCO research enterprise launching ASCO s first-ever clinical trial, increasing its ability to conduct observational studies, and tapping into the 40,000-person membership for original survey-based research. It was clear that while ASCO was a tremendous vehicle to disseminate and amplify research findings that were generated by various entities, ASCO itself didn t actually do any research to contribute any knowledge to the field, Schilsky told